Immunophenotyping of Acute b Cell Lymphoblstic Leukemia

South Egypt Cancer Institute50 enrolled

Overview

To study the immunophenotyping pattern of acute B lymphoblastic leukemia in south Egypt Cancer Institute iand its correlation with disease outcome

study the immunophenotyping pattern of acute B lymphoblastic leukemia in south Egypt Cancer Institute from 2009 -2019 and its correlation with disease outcome

Study Type

OBSERVATIONAL

Enrollment

Conditions

Acute Leukemia

Interventions

stastical analysisOTHER

1-Clinical examination data-Complete Blood Count (CBC).Bone Marrow Aspiration (BMA)-Bone Marrow Biopsy (BMB). (if available)-Immunophenotyping results (IPT).Cytogenetic results

Eligibility

Sex: ALLMin age: 12 MonthsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * New cases admitted to SECI Who didn't receive treatment.Age above 1 years old. Exclusion Criteria: * Cases who received treatment Patients below 1 years old.Patients diagnosed as AML or T-ALL

Outcomes

Primary Outcomes

overall survival outcome

Time frame: 10 years

Disease-free survival outcome

Time frame: 10 years

association of novel CD markers with old markers for assessment of disease outcome

Time frame: 10 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.